Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AQST · against 457 other Healthcare companies of similar size
Ranked #409 of 458 · scores higher than 11% of peers · safety percentile 11
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)37 peers with a safety percentile of 10–19, including AQST · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | AQST | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 425 reported | Not reported | 0.18× | — | — | 33% |
| BetaLower is better · 439 reported | 1.49 | 0.43 | 9% | 33% | |
| Current ratioHigher is better · 452 reported | 7.19× | 2.84× | 79% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 421M USD | 99 | 52 | |
| 2 | 261M USD | 99 | 97 | |
| 3 | 397M USD | 99 | 37 | |
| 4 | 455M USD | 99 | 53 | |
| 5 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 405 | 966M USD | 12 | 33 | |
| 406 | 1.9B CNY (≈$270M) | 12 | 17 | |
| 407 | 439M EUR (≈$482M) | 11 | 46 | |
| 408 | 427M USD | 11 | 7 | |
| 409 | 487M USD | 11 | 24 | |
| 410 | 838M USD | 11 | 33 | |
| 411 | 365M EUR (≈$401M) | 10 | 44 | |
| 412 | 522M USD | 10 | 12 | |
| 413 | 1.2B SGD (≈$945M) | 10 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score